Logo image of FRHC

FREEDOM HOLDING CORP/NV (FRHC) Stock Fundamental Analysis

NASDAQ:FRHC - Nasdaq - US3563901046 - Common Stock - Currency: USD

171.42  +12.09 (+7.59%)

After market: 171.42 0 (0%)

Fundamental Rating

3

FRHC gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 233 industry peers in the Capital Markets industry. While FRHC is still in line with the averages on profitability rating, there are concerns on its financial health. FRHC is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

FRHC had positive earnings in the past year.
FRHC had a positive operating cash flow in the past year.
FRHC had positive earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: FRHC reported negative operating cash flow in multiple years.
FRHC Yearly Net Income VS EBIT VS OCF VS FCFFRHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B -1B 1.5B

1.2 Ratios

FRHC has a Return On Assets of 0.85%. This is in the lower half of the industry: FRHC underperforms 66.95% of its industry peers.
FRHC has a Return On Equity (6.97%) which is comparable to the rest of the industry.
Looking at the Return On Invested Capital, with a value of 11.05%, FRHC belongs to the top of the industry, outperforming 85.41% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for FRHC is significantly above the industry average of 7.86%.
Industry RankSector Rank
ROA 0.85%
ROE 6.97%
ROIC 11.05%
ROA(3y)3.14%
ROA(5y)4.72%
ROE(3y)21.88%
ROE(5y)32.14%
ROIC(3y)12.87%
ROIC(5y)12.67%
FRHC Yearly ROA, ROE, ROICFRHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100 -200 -300 -400

1.3 Margins

FRHC has a Profit Margin of 4.26%. This is in the lower half of the industry: FRHC underperforms 67.38% of its industry peers.
FRHC's Profit Margin has declined in the last couple of years.
FRHC's Operating Margin of 29.44% is in line compared to the rest of the industry. FRHC outperforms 54.94% of its industry peers.
In the last couple of years the Operating Margin of FRHC has remained more or less at the same level.
Looking at the Gross Margin, with a value of 66.00%, FRHC is in the better half of the industry, outperforming 71.67% of the companies in the same industry.
FRHC's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 29.44%
PM (TTM) 4.26%
GM 66%
OM growth 3Y-22.66%
OM growth 5Y-1.08%
PM growth 3Y-49.56%
PM growth 5Y-27.11%
GM growth 3Y-6.02%
GM growth 5Y-4.18%
FRHC Yearly Profit, Operating, Gross MarginsFRHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

3

2. Health

2.1 Basic Checks

Compared to 1 year ago, FRHC has more shares outstanding
The number of shares outstanding for FRHC has been increased compared to 5 years ago.
FRHC has a better debt/assets ratio than last year.
FRHC Yearly Shares OutstandingFRHC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
FRHC Yearly Total Debt VS Total AssetsFRHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

FRHC has an Altman-Z score of 1.18. This is a bad value and indicates that FRHC is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.18, FRHC is in line with its industry, outperforming 56.65% of the companies in the same industry.
The Debt to FCF ratio of FRHC is 1.19, which is an excellent value as it means it would take FRHC, only 1.19 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.19, FRHC belongs to the top of the industry, outperforming 87.12% of the companies in the same industry.
A Debt/Equity ratio of 1.55 is on the high side and indicates that FRHC has dependencies on debt financing.
FRHC has a worse Debt to Equity ratio (1.55) than 74.25% of its industry peers.
Although FRHC does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 1.55
Debt/FCF 1.19
Altman-Z 1.18
ROIC/WACCN/A
WACCN/A
FRHC Yearly LT Debt VS Equity VS FCFFRHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B -1B 1.5B

2.3 Liquidity

A Current Ratio of 0.95 indicates that FRHC may have some problems paying its short term obligations.
With a Current ratio value of 0.95, FRHC is not doing good in the industry: 60.09% of the companies in the same industry are doing better.
A Quick Ratio of 0.95 indicates that FRHC may have some problems paying its short term obligations.
FRHC's Quick ratio of 0.95 is in line compared to the rest of the industry. FRHC outperforms 43.78% of its industry peers.
Industry RankSector Rank
Current Ratio 0.95
Quick Ratio 0.95
FRHC Yearly Current Assets VS Current LiabilitesFRHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

4

3. Growth

3.1 Past

The earnings per share for FRHC have decreased strongly by -78.36% in the last year.
The Earnings Per Share has been growing by 26.62% on average over the past years. This is a very strong growth
FRHC shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 19.19%.
Measured over the past years, FRHC shows a very strong growth in Revenue. The Revenue has been growing by 75.39% on average per year.
EPS 1Y (TTM)-78.36%
EPS 3Y-28.51%
EPS 5Y26.62%
EPS Q2Q%-251.31%
Revenue 1Y (TTM)19.19%
Revenue growth 3Y42.6%
Revenue growth 5Y75.39%
Sales Q2Q%-27.15%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
FRHC Yearly Revenue VS EstimatesFRHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
FRHC Yearly EPS VS EstimatesFRHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2 4 6

2

4. Valuation

4.1 Price/Earnings Ratio

FRHC is valuated quite expensively with a Price/Earnings ratio of 125.12.
FRHC's Price/Earnings ratio is a bit more expensive when compared to the industry. FRHC is more expensive than 77.68% of the companies in the same industry.
When comparing the Price/Earnings ratio of FRHC to the average of the S&P500 Index (27.48), we can say FRHC is valued expensively.
Industry RankSector Rank
PE 125.12
Fwd PE N/A
FRHC Price Earnings VS Forward Price EarningsFRHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, FRHC is valued a bit cheaper than the industry average as 79.83% of the companies are valued more expensively.
81.55% of the companies in the same industry are more expensive than FRHC, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 6.62
EV/EBITDA 15.59
FRHC Per share dataFRHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)4.7
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for FRHC!.
Industry RankSector Rank
Dividend Yield N/A

FREEDOM HOLDING CORP/NV

NASDAQ:FRHC (7/17/2025, 4:30:00 PM)

After market: 171.42 0 (0%)

171.42

+12.09 (+7.59%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)06-12 2025-06-12
Earnings (Next)08-08 2025-08-08
Inst Owners2.03%
Inst Owner Change0%
Ins Owners1.02%
Ins Owner Change1.77%
Market Cap10.49B
Analysts0
Price TargetN/A
Short Float %4.04%
Short Ratio4.32
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 125.12
Fwd PE N/A
P/S 5.28
P/FCF 6.62
P/OCF 6.24
P/B 8.64
P/tB 9.44
EV/EBITDA 15.59
EPS(TTM)1.37
EY0.8%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)25.91
FCFY15.11%
OCF(TTM)27.46
OCFY16.02%
SpS32.45
BVpS19.84
TBVpS18.15
PEG (NY)N/A
PEG (5Y)4.7
Profitability
Industry RankSector Rank
ROA 0.85%
ROE 6.97%
ROCE 20.59%
ROIC 11.05%
ROICexc 13.76%
ROICexgc 14.19%
OM 29.44%
PM (TTM) 4.26%
GM 66%
FCFM 79.83%
ROA(3y)3.14%
ROA(5y)4.72%
ROE(3y)21.88%
ROE(5y)32.14%
ROIC(3y)12.87%
ROIC(5y)12.67%
ROICexc(3y)15.36%
ROICexc(5y)14.75%
ROICexgc(3y)15.7%
ROICexgc(5y)14.99%
ROCE(3y)30.86%
ROCE(5y)27.65%
ROICexcg growth 3Y-4.1%
ROICexcg growth 5Y-1.29%
ROICexc growth 3Y-4.92%
ROICexc growth 5Y-1.3%
OM growth 3Y-22.66%
OM growth 5Y-1.08%
PM growth 3Y-49.56%
PM growth 5Y-27.11%
GM growth 3Y-6.02%
GM growth 5Y-4.18%
F-Score4
Asset Turnover0.2
Health
Industry RankSector Rank
Debt/Equity 1.55
Debt/FCF 1.19
Debt/EBITDA 3.14
Cap/Depr 555.59%
Cap/Sales 4.8%
Interest Coverage 1.14
Cash Conversion 279.29%
Profit Quality 1873.28%
Current Ratio 0.95
Quick Ratio 0.95
Altman-Z 1.18
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)535.11%
Cap/Depr(5y)365.28%
Cap/Sales(3y)4.06%
Cap/Sales(5y)2.69%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-78.36%
EPS 3Y-28.51%
EPS 5Y26.62%
EPS Q2Q%-251.31%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)19.19%
Revenue growth 3Y42.6%
Revenue growth 5Y75.39%
Sales Q2Q%-27.15%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-39.59%
EBIT growth 3Y10.29%
EBIT growth 5Y73.49%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y243.1%
FCF growth 3YN/A
FCF growth 5Y109.13%
OCF growth 1Y257.94%
OCF growth 3YN/A
OCF growth 5Y106.96%